Structure

Physi-Chem Properties

Molecular Weight:  414.13
Volume:  404.072
LogP:  2.679
LogD:  3.02
LogS:  -4.739
# Rotatable Bonds:  6
TPSA:  92.68
# H-Bond Aceptor:  8
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.57
Synthetic Accessibility Score:  3.682
Fsp3:  0.318
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  2
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.762
MDCK Permeability:  3.0105597033980303e-05
Pgp-inhibitor:  0.285
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.01
30% Bioavailability (F30%):  0.022

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.009
Plasma Protein Binding (PPB):  93.553466796875%
Volume Distribution (VD):  0.76
Pgp-substrate:  7.019983768463135%

ADMET: Metabolism

CYP1A2-inhibitor:  0.178
CYP1A2-substrate:  0.965
CYP2C19-inhibitor:  0.84
CYP2C19-substrate:  0.849
CYP2C9-inhibitor:  0.882
CYP2C9-substrate:  0.86
CYP2D6-inhibitor:  0.863
CYP2D6-substrate:  0.79
CYP3A4-inhibitor:  0.947
CYP3A4-substrate:  0.875

ADMET: Excretion

Clearance (CL):  13.562
Half-life (T1/2):  0.296

ADMET: Toxicity

hERG Blockers:  0.011
Human Hepatotoxicity (H-HT):  0.106
Drug-inuced Liver Injury (DILI):  0.545
AMES Toxicity:  0.048
Rat Oral Acute Toxicity:  0.611
Maximum Recommended Daily Dose:  0.758
Skin Sensitization:  0.4
Carcinogencity:  0.638
Eye Corrosion:  0.003
Eye Irritation:  0.417
Respiratory Toxicity:  0.949

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC477700

Natural Product ID:  NPC477700
Common Name*:   (4S)-3-Methylene-4-[alpha-(4-methoxy-1,3-benzodioxole-6-yl)-4-hydroxy-3,5-dimethoxybenzyl]tetrahydrofuran-2-one
IUPAC Name:   (4S)-4-[(4-hydroxy-3,5-dimethoxyphenyl)-(7-methoxy-1,3-benzodioxol-5-yl)methyl]-3-methylideneoxolan-2-one
Synonyms:  
Standard InCHIKey:  UGKOGWUDRSXQOZ-MJTSIZKDSA-N
Standard InCHI:  InChI=1S/C22H22O8/c1-11-14(9-28-22(11)24)19(12-5-15(25-2)20(23)16(6-12)26-3)13-7-17(27-4)21-18(8-13)29-10-30-21/h5-8,14,19,23H,1,9-10H2,2-4H3/t14-,19?/m1/s1
SMILES:  COC1=CC(=CC(=C1O)OC)C([C@@H]2COC(=O)C2=C)C3=CC4=C(C(=C3)OC)OCO4
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   11567816
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000134] Phenols
        • [CHEMONTID:0000190] Methoxyphenols

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO27718 Peperomia dindygulensis Species Piperaceae Eukaryota whole plant Yunnan Province, China 2002-FEB PMID[16309318]
NPO27718 Peperomia dindygulensis Species Piperaceae Eukaryota whole plant Yunnan Province, China 2002-FEB PMID[16724842]
NPO27718 Peperomia dindygulensis Species Piperaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1475 Cell Line WI-38 VA13 Homo sapiens IC50 = 13500 nM PMID[16724842]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 22300 nM PMID[16724842]
NPT81 Cell Line A549 Homo sapiens IC50 = 4230 nM PMID[16724842]
NPT81 Cell Line A549 Homo sapiens IC50 = 3160 nM PMID[16724842]
NPT81 Cell Line A549 Homo sapiens IC50 = 84700 nM PMID[16724842]
NPT27 Others Unspecified IC50 = 20900 nM PMID[16724842]
NPT2 Others Unspecified Activity = 104 % PMID[16724842]
NPT2 Others Unspecified Activity = 98 % PMID[16724842]
NPT2 Others Unspecified Activity = 125 % PMID[16724842]
NPT2 Others Unspecified Activity = 85 % PMID[16724842]
NPT2 Others Unspecified Activity = 83 % PMID[16724842]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC477700 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9861 High Similarity NPC32079
0.986 High Similarity NPC668
0.986 High Similarity NPC474965
0.986 High Similarity NPC174512
0.986 High Similarity NPC293757
0.986 High Similarity NPC477695
0.9722 High Similarity NPC145569
0.9722 High Similarity NPC216223
0.9658 High Similarity NPC477699
0.9527 High Similarity NPC136757
0.951 High Similarity NPC475000
0.9441 High Similarity NPC470811
0.9441 High Similarity NPC477696
0.9441 High Similarity NPC477697
0.9396 High Similarity NPC103197
0.9396 High Similarity NPC30009
0.9379 High Similarity NPC193779
0.9371 High Similarity NPC151423
0.9371 High Similarity NPC40237
0.9346 High Similarity NPC76687
0.9338 High Similarity NPC163527
0.9338 High Similarity NPC181168
0.9338 High Similarity NPC115281
0.932 High Similarity NPC477698
0.932 High Similarity NPC125570
0.931 High Similarity NPC477702
0.9306 High Similarity NPC273657
0.9306 High Similarity NPC106920
0.9262 High Similarity NPC56184
0.9247 High Similarity NPC212890
0.9241 High Similarity NPC218841
0.9241 High Similarity NPC92693
0.9236 High Similarity NPC176586
0.9236 High Similarity NPC210354
0.9216 High Similarity NPC150943
0.9216 High Similarity NPC91634
0.9216 High Similarity NPC268718
0.9195 High Similarity NPC164082
0.9167 High Similarity NPC166137
0.9167 High Similarity NPC282291
0.9133 High Similarity NPC476434
0.911 High Similarity NPC177644
0.911 High Similarity NPC191158
0.9073 High Similarity NPC473236
0.9048 High Similarity NPC474158
0.9041 High Similarity NPC474288
0.9038 High Similarity NPC14294
0.9038 High Similarity NPC116759
0.902 High Similarity NPC32373
0.902 High Similarity NPC237946
0.898 High Similarity NPC27159
0.8973 High Similarity NPC52664
0.8973 High Similarity NPC287124
0.8966 High Similarity NPC177868
0.8961 High Similarity NPC207584
0.8961 High Similarity NPC19947
0.8954 High Similarity NPC238834
0.8951 High Similarity NPC72796
0.8951 High Similarity NPC44245
0.8938 High Similarity NPC178737
0.8926 High Similarity NPC304687
0.8926 High Similarity NPC80230
0.8926 High Similarity NPC101755
0.8926 High Similarity NPC65574
0.8926 High Similarity NPC104024
0.8919 High Similarity NPC223185
0.8912 High Similarity NPC185071
0.8912 High Similarity NPC12728
0.8896 High Similarity NPC478055
0.8889 High Similarity NPC178195
0.8889 High Similarity NPC11453
0.8889 High Similarity NPC348849
0.8874 High Similarity NPC149505
0.8868 High Similarity NPC185498
0.8859 High Similarity NPC472560
0.8859 High Similarity NPC3982
0.8851 High Similarity NPC477701
0.8851 High Similarity NPC141569
0.8851 High Similarity NPC166884
0.8846 High Similarity NPC474770
0.8846 High Similarity NPC119910
0.8844 High Similarity NPC253481
0.8844 High Similarity NPC31751
0.8844 High Similarity NPC253722
0.8831 High Similarity NPC476065
0.8824 High Similarity NPC115466
0.8824 High Similarity NPC245948
0.8824 High Similarity NPC245615
0.8824 High Similarity NPC178574
0.8824 High Similarity NPC61604
0.8824 High Similarity NPC299706
0.8824 High Similarity NPC474606
0.8824 High Similarity NPC65591
0.8819 High Similarity NPC211386
0.8816 High Similarity NPC13985
0.8816 High Similarity NPC210642
0.8816 High Similarity NPC303519
0.8816 High Similarity NPC475756
0.8812 High Similarity NPC117911
0.8808 High Similarity NPC177476
0.8808 High Similarity NPC262455
0.879 High Similarity NPC100465
0.879 High Similarity NPC115624
0.879 High Similarity NPC288149
0.879 High Similarity NPC152424
0.8784 High Similarity NPC298317
0.8784 High Similarity NPC255566
0.8782 High Similarity NPC76211
0.8776 High Similarity NPC100675
0.8766 High Similarity NPC312763
0.8766 High Similarity NPC198461
0.8759 High Similarity NPC90431
0.8758 High Similarity NPC471154
0.8758 High Similarity NPC179240
0.875 High Similarity NPC300776
0.875 High Similarity NPC24425
0.875 High Similarity NPC4982
0.875 High Similarity NPC176814
0.875 High Similarity NPC311912
0.875 High Similarity NPC68779
0.875 High Similarity NPC5310
0.8742 High Similarity NPC475738
0.8742 High Similarity NPC40654
0.8742 High Similarity NPC262804
0.8742 High Similarity NPC304821
0.8726 High Similarity NPC96593
0.8718 High Similarity NPC475592
0.8718 High Similarity NPC472860
0.8718 High Similarity NPC474990
0.871 High Similarity NPC38699
0.8699 High Similarity NPC474039
0.8699 High Similarity NPC283949
0.8696 High Similarity NPC88557
0.869 High Similarity NPC34103
0.869 High Similarity NPC150534
0.869 High Similarity NPC141765
0.869 High Similarity NPC165155
0.869 High Similarity NPC24490
0.8688 High Similarity NPC174734
0.8688 High Similarity NPC474042
0.8681 High Similarity NPC205915
0.8654 High Similarity NPC163635
0.8649 High Similarity NPC470991
0.8645 High Similarity NPC287504
0.8645 High Similarity NPC273578
0.8636 High Similarity NPC95498
0.8636 High Similarity NPC246566
0.8634 High Similarity NPC79322
0.863 High Similarity NPC143895
0.8627 High Similarity NPC158635
0.8627 High Similarity NPC229882
0.8627 High Similarity NPC473989
0.8625 High Similarity NPC222531
0.8618 High Similarity NPC252402
0.8618 High Similarity NPC130449
0.8618 High Similarity NPC248132
0.8618 High Similarity NPC102934
0.8608 High Similarity NPC239966
0.8608 High Similarity NPC203020
0.86 High Similarity NPC118385
0.86 High Similarity NPC187774
0.86 High Similarity NPC472712
0.86 High Similarity NPC472713
0.86 High Similarity NPC473046
0.8599 High Similarity NPC1913
0.859 High Similarity NPC186316
0.8581 High Similarity NPC24562
0.8581 High Similarity NPC226547
0.8581 High Similarity NPC217708
0.8581 High Similarity NPC56091
0.8581 High Similarity NPC77237
0.8581 High Similarity NPC308739
0.8581 High Similarity NPC46591
0.8581 High Similarity NPC44730
0.8581 High Similarity NPC126405
0.8581 High Similarity NPC53669
0.8581 High Similarity NPC297271
0.8581 High Similarity NPC16791
0.8571 High Similarity NPC306475
0.8571 High Similarity NPC185908
0.8571 High Similarity NPC281780
0.8562 High Similarity NPC99572
0.8562 High Similarity NPC85141
0.8562 High Similarity NPC135777
0.8562 High Similarity NPC126409
0.8562 High Similarity NPC475865
0.8562 High Similarity NPC469518
0.8562 High Similarity NPC55158
0.8562 High Similarity NPC469475
0.8562 High Similarity NPC286235
0.8562 High Similarity NPC142547
0.8562 High Similarity NPC51328
0.8562 High Similarity NPC113295
0.8553 High Similarity NPC209411
0.8553 High Similarity NPC239890
0.8545 High Similarity NPC196771
0.8544 High Similarity NPC472565
0.8544 High Similarity NPC289811
0.8544 High Similarity NPC215400
0.8544 High Similarity NPC241600

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC477700 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9276 High Similarity NPD6234 Discontinued
0.902 High Similarity NPD4966 Approved
0.902 High Similarity NPD4967 Phase 2
0.902 High Similarity NPD4965 Approved
0.8868 High Similarity NPD7228 Approved
0.8824 High Similarity NPD37 Approved
0.8553 High Similarity NPD7199 Phase 2
0.8447 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8421 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.8383 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.8377 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD7240 Approved
0.8293 Intermediate Similarity NPD3818 Discontinued
0.8187 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8118 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8075 Intermediate Similarity NPD3882 Suspended
0.8027 Intermediate Similarity NPD3027 Phase 3
0.7933 Intermediate Similarity NPD230 Phase 1
0.7921 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD7685 Pre-registration
0.787 Intermediate Similarity NPD7074 Phase 3
0.7862 Intermediate Similarity NPD1653 Approved
0.784 Intermediate Similarity NPD1465 Phase 2
0.7836 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7811 Intermediate Similarity NPD7054 Approved
0.7792 Intermediate Similarity NPD7266 Discontinued
0.7778 Intermediate Similarity NPD1934 Approved
0.7765 Intermediate Similarity NPD7472 Approved
0.7747 Intermediate Similarity NPD7680 Approved
0.773 Intermediate Similarity NPD2801 Approved
0.7725 Intermediate Similarity NPD6232 Discontinued
0.7707 Intermediate Similarity NPD6190 Approved
0.7692 Intermediate Similarity NPD7473 Discontinued
0.7683 Intermediate Similarity NPD3817 Phase 2
0.7674 Intermediate Similarity NPD6559 Discontinued
0.7622 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7616 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7616 Intermediate Similarity NPD6797 Phase 2
0.7616 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7603 Intermediate Similarity NPD3705 Approved
0.759 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7572 Intermediate Similarity NPD7251 Discontinued
0.7533 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD4628 Phase 3
0.7532 Intermediate Similarity NPD4110 Phase 3
0.7529 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD6166 Phase 2
0.7529 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD7808 Phase 3
0.7516 Intermediate Similarity NPD1613 Approved
0.7516 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5844 Phase 1
0.75 Intermediate Similarity NPD5494 Approved
0.7485 Intermediate Similarity NPD7075 Discontinued
0.7483 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD6355 Discontinued
0.7453 Intermediate Similarity NPD2533 Approved
0.7453 Intermediate Similarity NPD2532 Approved
0.7453 Intermediate Similarity NPD2534 Approved
0.7439 Intermediate Similarity NPD7028 Phase 2
0.7421 Intermediate Similarity NPD3750 Approved
0.7421 Intermediate Similarity NPD7827 Phase 1
0.7421 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD7819 Suspended
0.7391 Intermediate Similarity NPD4357 Discontinued
0.7391 Intermediate Similarity NPD6799 Approved
0.7391 Intermediate Similarity NPD1511 Approved
0.7374 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD5242 Approved
0.7333 Intermediate Similarity NPD4380 Phase 2
0.7333 Intermediate Similarity NPD6599 Discontinued
0.7315 Intermediate Similarity NPD1608 Approved
0.7312 Intermediate Similarity NPD8166 Discontinued
0.7305 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD9494 Approved
0.7301 Intermediate Similarity NPD1512 Approved
0.729 Intermediate Similarity NPD4060 Phase 1
0.7278 Intermediate Similarity NPD2935 Discontinued
0.7273 Intermediate Similarity NPD3764 Approved
0.7267 Intermediate Similarity NPD2983 Phase 2
0.7267 Intermediate Similarity NPD3926 Phase 2
0.7267 Intermediate Similarity NPD2982 Phase 2
0.7262 Intermediate Similarity NPD5353 Approved
0.7262 Intermediate Similarity NPD5402 Approved
0.7255 Intermediate Similarity NPD4908 Phase 1
0.7251 Intermediate Similarity NPD8127 Discontinued
0.7246 Intermediate Similarity NPD6801 Discontinued
0.7235 Intermediate Similarity NPD919 Approved
0.7222 Intermediate Similarity NPD5283 Phase 1
0.7219 Intermediate Similarity NPD7768 Phase 2
0.7215 Intermediate Similarity NPD1510 Phase 2
0.7209 Intermediate Similarity NPD7229 Phase 3
0.7202 Intermediate Similarity NPD8455 Phase 2
0.72 Intermediate Similarity NPD2981 Phase 2
0.72 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD9269 Phase 2
0.7198 Intermediate Similarity NPD7296 Approved
0.719 Intermediate Similarity NPD3018 Phase 2
0.7186 Intermediate Similarity NPD7411 Suspended
0.7179 Intermediate Similarity NPD943 Approved
0.7179 Intermediate Similarity NPD1240 Approved
0.7171 Intermediate Similarity NPD2797 Approved
0.717 Intermediate Similarity NPD6099 Approved
0.717 Intermediate Similarity NPD6100 Approved
0.717 Intermediate Similarity NPD2438 Suspended
0.717 Intermediate Similarity NPD1551 Phase 2
0.7169 Intermediate Similarity NPD7458 Discontinued
0.7162 Intermediate Similarity NPD1357 Approved
0.7161 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD6798 Discontinued
0.7152 Intermediate Similarity NPD5403 Approved
0.7143 Intermediate Similarity NPD5536 Phase 2
0.7134 Intermediate Similarity NPD447 Suspended
0.7134 Intermediate Similarity NPD1933 Approved
0.7134 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD1610 Phase 2
0.7115 Intermediate Similarity NPD6233 Phase 2
0.7114 Intermediate Similarity NPD17 Approved
0.7107 Intermediate Similarity NPD3748 Approved
0.7105 Intermediate Similarity NPD1283 Approved
0.7104 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD5563 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD7095 Approved
0.7095 Intermediate Similarity NPD8312 Approved
0.7095 Intermediate Similarity NPD8313 Approved
0.7089 Intermediate Similarity NPD1607 Approved
0.7083 Intermediate Similarity NPD6386 Approved
0.7083 Intermediate Similarity NPD228 Approved
0.7083 Intermediate Similarity NPD6385 Approved
0.7083 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD1549 Phase 2
0.7076 Intermediate Similarity NPD3749 Approved
0.707 Intermediate Similarity NPD3620 Phase 2
0.707 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD3268 Approved
0.7045 Intermediate Similarity NPD3751 Discontinued
0.7037 Intermediate Similarity NPD6674 Discontinued
0.7037 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD5005 Approved
0.7037 Intermediate Similarity NPD5006 Approved
0.703 Intermediate Similarity NPD5401 Approved
0.703 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD422 Phase 1
0.7019 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD6004 Phase 3
0.7019 Intermediate Similarity NPD6002 Phase 3
0.7019 Intermediate Similarity NPD6005 Phase 3
0.7011 Intermediate Similarity NPD3787 Discontinued
0.7006 Intermediate Similarity NPD4062 Phase 3
0.7 Intermediate Similarity NPD2799 Discontinued
0.6981 Remote Similarity NPD6653 Approved
0.6977 Remote Similarity NPD6971 Discontinued
0.6975 Remote Similarity NPD5958 Discontinued
0.6964 Remote Similarity NPD3455 Phase 2
0.6962 Remote Similarity NPD2979 Phase 3
0.6957 Remote Similarity NPD2796 Approved
0.6954 Remote Similarity NPD1247 Approved
0.6944 Remote Similarity NPD7549 Discontinued
0.6944 Remote Similarity NPD3022 Approved
0.6944 Remote Similarity NPD3021 Approved
0.6937 Remote Similarity NPD7097 Phase 1
0.6933 Remote Similarity NPD9268 Approved
0.6928 Remote Similarity NPD4749 Approved
0.6928 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6915 Remote Similarity NPD4420 Approved
0.6914 Remote Similarity NPD5711 Approved
0.6914 Remote Similarity NPD5710 Approved
0.6908 Remote Similarity NPD1281 Approved
0.6907 Remote Similarity NPD8151 Discontinued
0.6906 Remote Similarity NPD7280 Phase 3
0.6906 Remote Similarity NPD7281 Phase 3
0.6903 Remote Similarity NPD5647 Approved
0.6901 Remote Similarity NPD2978 Approved
0.6901 Remote Similarity NPD2977 Approved
0.6894 Remote Similarity NPD7033 Discontinued
0.6886 Remote Similarity NPD6273 Approved
0.6885 Remote Similarity NPD8434 Phase 2
0.6879 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6871 Remote Similarity NPD4534 Discontinued
0.6867 Remote Similarity NPD1894 Discontinued
0.6867 Remote Similarity NPD1548 Phase 1
0.6867 Remote Similarity NPD9545 Approved
0.6859 Remote Similarity NPD2861 Phase 2
0.6857 Remote Similarity NPD6959 Discontinued
0.6848 Remote Similarity NPD5307 Clinical (unspecified phase)
0.6845 Remote Similarity NPD920 Approved
0.6842 Remote Similarity NPD3847 Discontinued
0.6835 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6833 Remote Similarity NPD5953 Discontinued
0.6832 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6829 Remote Similarity NPD2800 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data